Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

AZD2014 in RICTOR Amplified Solid Cancer

Trial Profile

AZD2014 in RICTOR Amplified Solid Cancer

Not yet recruiting
Phase of Trial: Phase II

Latest Information Update: 22 Jan 2018

At a glance

  • Drugs Vistusertib (Primary)
  • Indications Biliary cancer; Colorectal cancer; Gastric cancer; Liver cancer; Neuroendocrine carcinoma; Pancreatic cancer; Sarcoma; Solid tumours
  • Focus Therapeutic Use
  • Acronyms RICTOR_SC
  • Most Recent Events

    • 15 Jan 2018 Planned initiation date changed from 1 Jul 2017 to 1 Mar 2018.
    • 29 May 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top